Benzyl Alcohol is an aromatic alcohol used in a wide variety of cosmetic formulations as a fragrance component, preservative, solvent, and viscosity-decreasing agent. Benzoic Acid is an aromatic acid used in a wide variety of cosmetics as a pH adjuster and preservative. Sodium Benzoate is the sodium salt of Benzoic Acid used as a preservative, also in a wide range of cosmetic product types. Benzyl Alcohol is metabolized to Benzoic Acid, which reacts with glycine and excreted as hippuric acid in the human body. Acceptable daily intakes were established by the World Health Organization at 5 mg/kg for Benzyl Alcohol, Benzoic Acid, and Sodium Benzoate. Benzoic Acid and Sodium Benzoate are generally recognized as safe in foods according to the U.S. Food and Drug Administration. No adverse effects of Benzyl Alcohol were seen in chronic exposure animal studies using rats and mice. Effects of Benzoic Acid and Sodium Benzoate in chronic exposure animal studies were limited to reduced feed intake and reduced growth. Some differences between control and Benzyl Alcohol-treated populations were noted in one reproductive toxicity study using mice, but these were limited to lower maternal body weights and decreased mean litter weights. Another study also noted that fetal weight was decreased compared to controls, but a third study showed no differences between control and Benzyl Alcohol-treated groups. Benzoic Acid was associated with an increased number of resorptions and malformations in hamsters, but there were no reproductive or developmental toxicty findings in studies using mice and rats exposed to Sodium Benzoate, and, likewise, Benzoic Acid was negative in two rat studies. Genotoxicity tests for these ingredients were mostly negative, but there were some assays that were positive. Carcinogenicity studies, however, were negative. Clinical data indicated that these ingredients can produce nonimmunologic contact urticaria and nonimmunologic immediate contact reactions, characterized by the appearance of wheals, erythema, and pruritis. In one study, 5% Benzyl Alcohol elicited a reaction, and in another study, 2% Benzoic Acid did likewise. Benzyl Alcohol, however, was not a sensitizer at 10%, nor was Benzoic Acid a sensitizer at 2%. Recognizing that the nonimmunologic reactions are strictly cutaneous, likely involving a cholinergic mechanism, it was concluded that these ingredients could be used safely at concentrations up to 5%, but that manufacturers should consider the nonimmunologic phenomena when using these ingredients in cosmetic formulations designed for infants and children. Additionally, Benzyl Alcohol was considered safe up to 10% for use in hair dyes. The limited body exposure, the duration of use, and the frequency of use were considered in concluding that the nonimmunologic reactions would not be a concern. Because of the wide variety of product types in which these ingredients may be used, it is likely that inhalation may be a route of exposure. The available safety tests are not considered sufficient to support the safety of these ingredients in formulations where inhalation is a route of exposure. Inhalation toxicity data are needed to complete the safety assessment of these ingredients where inhalation can occur.
References
1.
Abe, S., and M. Sasaki. 1977. Chromosome aberrations and sister chromatid exchanges in Chinese hamster cells exposed to various chambers. J. Natl. Cancer Inst.58:1635–1641.
2.
Adams, R. M.1982. Patch testing in occupational dermatitis. In Occupational and Industrial Dermatology, ed. H. I. Maibach and G. A. Gellin, 345–352. Chicago: Year Book Medical Publishers.
3.
Adams, R. M., and H. I. Maibach. 1985. A five-year study of cosmetic reactions. J. Am. Acad. Dermatol.13:1062–1069.
4.
Ahkong, Q. F., G. M. Botham, A. W. Woodward, and J. A. Lucy. 1980. Calcium-activated thiol-proteinase activity in the fusion of rat erythrocytes induced by benzyl alcohol. Biochem. J.192:829–836.
5.
Amsel, L. P., and G. Levy. 1969. Drug biotransformation interactions in man. II. A pharmacokinetic study of the simultaneous conjugation of benzoic and salicylic acids with glycine. J. Pharm. Sci.58:321–326.
6.
Anderson, B. E., E. Zeiger, M. D. Shelby, M. A. Resnick, D. K. Gulati, J. L. Ivett, and K. S. Loveday. 1990. Chromosome aberration and sister chromatid exchange test results with 42 chemicals. Environ. Mol. Mutagen.16(Suppl 18):55–137.
7.
Ball, J. C., S. Foxall-Van Aken, and T. E. Jensen. 1984. Mutagenicity studies of p-substituted benzyl derivatives in the Ames Salmonella plate-incorporation assay. Mutat. Res.138:145–151.
8.
Basketter, D. A., and K. P. Wilhelm. 1996. Studies on non-immune immediate contact reactions in an unselected population. Contact Dermatitis35:237–240.
9.
Bassé, F., J. Sainte-Marie, L. Maurin, and A. Bienvenüe. 1992. Effect of benzyl alcohol on phospholipid transverse mobility in human erythrocyte membrane. Eur J. Biochem.205:155–162.
10.
Benda, G. I., J. L. Hiller, and J. W. Reynolds. 1986. Benzyl alcohol toxicity: impact on neurologic handicaps among surviving very low birth weight infants. Pediatrics77:507–512.
11.
Bignami, G., and L. Boraccia. 1924. Investigations on hippuric synthesis in human organism. Boll. Soc. Med. Chir. Pazia.36:121–137.
12.
Biosearch Inc.1991. Draize-Shelanski repeat insult patch test conducted with eye shadow containing 0.1% Benzoic Acid. Two studies testing a matte formula # 3073–16 and base formula # 3073–17 on the same panelists. Project No. 90–7183H. Unpublished data submitted by CTFA. (46 pages.)2
13.
Biosearch Inc.1992a. Irritation screening study of face make-up containing 0.2% Benzoic Acid. Project No. 92–7569H. Unpublished data submitted by CTFA. (12 pages.)2
14.
Biosearch Inc.1992b. Modified Draize repeated insult patch study of face makeup containing 0.2% Benzoic Acid. Project No. 92- 7569H. Unpublished data submitted by CTFA. (11 pages.)2
15.
Biosearch Inc.1992c. Human phototoxicity study of face make-up containing 0.2% Benzoic Acid. Project No. 92–7569H. Unpublished data submitted by CTFA. (8 pages.)2
16.
Biosearch Inc.1992d. Human photoallergy test of face make-up containing 0.2% Benzoic Acid. Project No. 92–7569H. Unpublished data submitted by CTFA. (9 pages.)2
17.
Brada, Z., and S. Bulba. 1980. In vivo D-ethionine inversion and its inhibition. Res. Commun. Chem. Pathol. Pharmacol.30:341–360
18.
Bridges, J. W., M. R. French, R. L. Smith, and R. T. Williams. 1970. The fate of benzoic acid in various species. Biochem. J.118:47–51.
19.
Broeckx, W., A. Blondeel, A. Dooms-Goossens, and G. Achten. 1987. Cosmetic Intolerance. Contact Dermatitis16:189–194.
20.
Bronaugh, R. L., and T. J. Franz. 1986. Vehicle effects on percutaneous absorption: In vivo and in vitro comparisons with human skin. Br. J. Dermatol.115:1–11.
21.
Brown, W. J., N. R. M. Buist, H. T. C. Gipson, et al. 1982. Fatal benzyl alcohol poisoning in a neonatal intensive care unit. Lancet1:250.
22.
Brusilow, S. W., M. Danney, L. J. Waber, M. Batshaw, et al. 1980. Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis. N. Engl. J. Med.310:1630–1634.
23.
Brusilow, S. W., D. L. Valle, M. L. Batshaw. 1979. New pathways of nitrogen excretion in inborn errors of urea synthesis. LancetII:452–454.
24.
Budavari, S., ed. 1989. The Merck index: An encyclopedia of chemicals, drugs and biologicals, 10th ed., 170, 176, 1357. Rahway, NJ: Merck and Co.
25.
Burgen, A. S., C. M. Collecy, J. C., Metcalfe, S. M. Metcalfe, and C. B. Turner. 1970. The binding of benzyl alcohol to erythrocyte membranes. Br. J. Pharmacol.39:217.
26.
Carpenter, C. P., H. F. Smyth, Jr., and U. C. Pozzani. 1949. The assay of acute vapor toxicity, and the grading and interpretation of results on ninety-six compounds. J. Ind. Hyg. Toxicol.31:343–346.
27.
Cervantes, A., H. M. Pinedo, J. Lankelma, and G. J. Schuurhuis. 1988. The role of oxygen-derived free radicals in the cytotoxicity of doxorubicin in multi-drug resistant and sensitive human ovarian cancer cells. Cancer Lett.41:169–177.
28.
Chemnitius, K. H., M. Oettel, and H. Lemke. 1979. Teratogenic effects of ethinylestradiol sulfonate in Wistar rats. Eval. Embryotoxic. Mutagen Carcinog Risks New Drugs75–81.
29.
Cheung, K., A. C. Archibald, and M. F. Robinson. 1984. Luminol-dependent chemiluminescence produced by neutrophils stimulated by immune complexes. Aust. J. Exp. Biol. Med. Sci.62(pt 4):403–419.
30.
Craig, D. B., and G. G. Habib. 1977. Flaccid paraparesis following obstetrical epidural anesthesia: possible role of benzyl alcohol. Anesth. Analg.56:219–221.
31.
Crane, S. C., and P. A. Lachance. 1985. The effect of chronic sodium benzoate consumption on brain monamines and spontaneous activity in rats. Nutr. Rep. Int.31:169–177.
32.
Cronin, C. M., D. R. Brown, and M. Ahdab-Barmada. 1991. Risk factors associated with kernicterus in the newborn infant: Importance of benzyl alcohol exposure. Am. J. Perinatol.8:80–85.
33.
Daniel, L. N., Y. Mao, and U. Saffiotti. 1993. Oxidative DNA damage by crystalline silica. Free. Radic. Biol. Med.14:463–472.
34.
DeGroot, A. C.1994. Patch testing: Test concentrations and vehicles for 3700 chemicals, 2nd ed., 38, 40, 242, 301–302. Amsterdam: Elsevier.
35.
Deuel, H. G., Jr., R. Alfin-Slater, C. S. Weil, and H. F. Smyth. 1954. Sorbic acid as a fungistatic agent for foods. I. Harmlessness of sorbic acid as a dietary component. Food Res.19:1–12.
36.
Downard, C. D., L. J. Roberts II, and J. D. Morrow. 1995. Topical benzoic acid induces the increased biosynthesis of prostaglandin D2 in human skin in vivo. Clin. Pharmacol. Ther.57:441–445.
37.
Eberlein-König, B., T. Bergner, S. Diemer, and B. Przybilla. 1993. Evaluation of phototoxic properties of some food additives: Sulfites exhibit prominent phototoxicity. Acta Dermato-Venereal.73:362–364.
38.
Ebihara, L., J. E. Hall, R. C. MacDonald, T. J. McIntosh, and S. A. Simon. 1979. Effect of benzyl alcohol on lipid bilayers. A comparison of bilayer systems. Biophys. J.28:185–196.
39.
Education and Research Foundation, Inc.1992. 45-Day usage study in humans—acnegenicity and irritancy of liquid/powder foundation containing 0.2% Benzoic Acid. Unpublished data submitted by CTFA. (250 pages.)2
40.
Emmons, W. W., and J. G. Marks, Jr. 1985. Immediate and delayed reactions to cosmetic ingredients. Contact Dermatitis13:258–265.
41.
Environmental Health Research & Testing, Inc.1986. Screening of priority chemicals for reproductive hazards: Benzyl alcohol, probenecid, trans-retinoic acid. National Technical Information Service (NTIS) report no. PB89–139059. Springfield, VA: NTIS.
42.
Environmental Protection Agency (EPA).1989. Health and environmental effects document for benzyl alcohol. NTIS Report No. PB91–213694.
43.
European Union (EU). 1995. The Cosmetics Directive of the European Union. Updated version—incorporating all amendments until August 1, 1995. Dir. 76/768/EEC.
44.
Evangelista, S., and A. Meli. 1985. Influence of antioxidants and radical scavengers on ethanol-induced gastric ulcers in the rat. Gen. Pharmacol.16:285–286.
45.
Fanelli, G. M., and S. L. Halliday. 1963. Relative toxicity of chlortetracycline and sodium benzoate after oral administration to rats. Arch. Int. Pharmacodyn.114:120–125.
46.
Federation of American Societies for Experimental Biology (FASEB).1973. Evaluation of the health aspects of benzoic acid and sodium benzoate as food ingredients. NTIS Report No. PB-223–837.
47.
Feldmann, R. J., and H. I. Maibach. 1970. Absorption of some organic compounds through the skin in man. J. Invest. Dermatol.54:399–404.
48.
Flavor and Extract Manufacturers' Association.1984. Scientific literature review of Benzyl Alcohol, Benzaldehyde, Benzoic Acid and related compounds in flavor usage. Volume 1. Introduction and summary, tables of data, bibliography. NTIS Report No. PB85–141216.
49.
Fisher, A. A.1990. Contact urticaria due to occupational exposures. In Occupational skin disease ed. R. M. Adams, 113–126. Philadelphia: WB Saunders.
50.
Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO).1994. Summary of evaluations performed by the Joint FAO/WHO Expert Committee on Food Additives (JECFA).Washington, DC: International Life Sciences Institute.
51.
Food and Drug Administration (FDA).1982. Benzyl Alcohol may be toxic to newborns. FDA Drug Bull.12:10–11.
52.
FDA.1984. Cosmetic product formulation and frequency of use data. FDA database. Washington, DC: FDA.
53.
FDA.1992. Modification in Voluntary Filing of Cosmetic Product Ingredient and Cosmetic Raw Composition Statements. Final rule. Fed. Register57:3128–3130.
54.
2 Available for review: Director, Cosmetic Ingredient Review, 1101 17th St. NW, Suite 310, Washington, DC 20036–4702, USA.
55.
FDA.1998. Cosmetic product formulation data. FDA database. Washington, DC: FDA.
56.
Food and Drug Research Labs., Inc.1972. Teratologic evaluation of FDA 71–37 (sodium benzoate). NTIS Report No. PB-221–777.
57.
Forsbeck, M., and E. Skog. 1977. Immediate reactions to patch tests with balsam of Peru. Contact Dermatitis3:201–205.
58.
Foureman, P., J. M. Mason, R. Valencia, and S. Zimmering. 1994. Chemical mutagenesis testing in Drosophila: X. Results of 70 coded chemicals tested for the National Toxicology Program. Environ. Mol. Mutagen23:208–227.
59.
Frenken, L. A., H. J. van Lier, and R. A. Koene. 1994. Analysis of the efficacy of measures to reduce pain after subcutaneous administration of epoetin alfa [comment.]Nephrol. Dial. Transplant9:1295–1298.
60.
Fujita, H., and M. Sasaki. 1986. Mutagenicity test of food additives with Salmonella typhimurium TA97A and TA101. Kenkyu Nenpo- Tokyo- Toritsu Eisei Kenkyusho.37:447–52. (Obtained on-line from NLM's Chemical Carcinogenesis Research Info System [CCRIS] database.)
61.
Fujitani, T.1993. Short-term effect of sodium benzoate in F344 rats and B6C3F1 mice. Taxicol. Lett. (Amst)69:171–179.
62.
Gagliardi, L., A. Amato, A. Basili, G. Cavazzutti, E. Gattavecchia, and D. Tonelli. 1984. Determination of preservatives in cosmetic products by reversed-phase high-performance liquid chromatography. J. Chromatogr.315:465–469.
63.
Gershanik, J., B. Boecler, H. Ensley, S. McCloskey, and W. George. 1982. The gasping syndrome and benzyl alcohol poisoning. N. Engl. J. Med.307:1384–1388.
64.
Gordon, L. M., R. D. Sauerheber, J. A. Esgate, I. Dipple, R. J. Marchmont, and M. D. Houslay. 1980. The increase in bilayer fluidity of rat liver plasma membranes achieved by the local anesthetic benzyl alcohol affects the activity of intrinsic membrane enzymes. J. Biol. Chem.255:4519–4527.
65.
Gouyette, A., M. D. Kitzis, J. Guibert, and J. F. Acar. 1982. Pharmacokinetics and bioavailability of intramuscular preparations of ticarcillin. J. Antimicrob. Chemother.10(Nov):419–425.
66.
Grad, H., and M. Grushka. 1986. Dental pain treatment with nonprescription drugs. On Contin. Pract.13(April): 16–21.
67.
Grankvist, K., J. Sehlin, and I. B. Taeljedal. 1986. Rubidium uptake by mouse pancreatic islets exposed to 6-hydroxydopamine, ninhydrin, or other generators of hydroxyl radicals. Acta Pharmacol. Toxicol.58:175–181.
68.
Gregus, Z., T. Fekete, E. Halászi, and C.D. Klaassen. 1996. Lipoic acid impairs glycine conjugation of benzoic acid and renal excretion of benzoglycine. Drug Meta. Disposit.24:682–688.
69.
Gregus, Z., T. Fekete, F. Varga, and C. D. Klaassen. 1993. Effect of valproic acid on glycine conjugation of benzoic acid. J. Pharm. Exp. Ther.267:1068–1074.
70.
Griffith, W. H.1929. Growth of rats on diets containing sodium benzoate. Proc. Soc. Exp. Biol. Med.26:354–355.
71.
Guin, J. D., B. N. Meyer, R. D. Drake, and P. Haffley. 1984. The effect of quenching agents on contact urticaria caused by cinnamic aldehyde. J. Am. Acad. Dermatol.10:45–51.
72.
Hahn, A. F., T. E. Feasby, and J. J. Gilbert. 1983. Parapesis following intrathecal chemotherapy. Neurology33:1032–1038.
73.
Hannuksela, M., and T. Haahtela. 1987. Hypersensitivity reactions to food additives. Allergy42:561–575.
74.
Hardin, B. D., R. L. Schuler, J. R. Burg, G. M. Booth, K. P. Hazelden, K. M. Mackenzie, V. J. Piccirillo, and K. N. Smith. 1987. Evaluation of 60 chemicals in a preliminary developmental toxicity test. Teratat. Carcin. Mutag.7:29–48.
75.
Harvell, J. D., Y.-C. Tsai, H. I. Maibach, R. Gay, et al. 1994. An in vivo correlation with three in vitro assays to assess skin irritation potential. J. Toxicol. Cutan. Ocul. Toxicol.13:171–183.
76.
Hiller, J. L., G. I. Benda, M. Rahatzad, J. R., Allen, D. H. Culver, C. V. Carlson, and J. W. Reynolds. 1986. Benzyl alcohol toxicity: Impact on mortality and intraventricular hemorrhage among very low birth weight infants. Pediatrics77:500–506.
77.
Hill Top Research.1997a. Human repeat insult patch test of mascara containing 0.65% Benzyl Alcohol (test article # 4111–143). Project No. 96–0121–73. Unpublished data submitted by CTFA. (37 pages.)2
78.
Hill Top Research.1997b. Human repeat insult patch test of mascara containing 0.65% Benzyl Alcohol (test article # 4135–81). Project No. 96–0121–73. Unpublished data submitted by CTFA. (37 pages.)2
79.
Ibero, M., J. L. Eseverri, C. Barroso, and J. Botey. 1982. Dyes, preservatives and salicylates in the induction of food intolerance and/or hypersensitivity in children. Allergol. Immunopathol. (Madr)10:263–268.
80.
Ignatév, A. D.1965. Experimental information contributing to a hygienic characterization of the combined effect produced by some chemical food preservatives. Vop. Pitan.24:61–68.
81.
Informatics, Inc.1972. GRAS (generally recognized as safe) food ingredients: Benzoic Acid and Sodium Benzoate. NTIS Report No. PB-221–208.
82.
Inveresk Research International Ltd.1983. Screening of priority chemicals for reproductive hazard. NTIS Report No. PB83–258616.
83.
Ishidate, M., Jr., and S. Odashima. 1977. Chromosome tests with 134 compounds on Chinese hamster cells in vitro—a screening for chemical carcinogens. Mutat. Res.48:344–345.
84.
Jacobs, M. M., C. M. Burnett, A. J. Penicnak, J. A. Herrera, W. E. Morris, P. Shubik, M. Apaja, and G. Granroth. 1984. Evaluation of the toxicity and carcinogenicity of hair dyes in Swiss mice. Drug Chem. Toxicol.7:573–586.
85.
Japan Ministry of Health and Welfare.2000. Pharmaceutical and Medical Safety Bureau Notification No. 990. Partial amendments to the enforcement regulations of the Pharmaceutical Affairs Law pertaining to the relaxation of regulations for cosmetics. September 29, 2000. Unofficial translation from Japanese.
86.
Jardine, D. S., and K. Rogers. 1989. Relationship of benzyl alcohol to kernicterus, intraventricular hemorrhage, and mortality in preterm infants. Pediatrics83:153–160.
87.
Jørgensen, J. T.1994. Improvement of patient convenience in treatment with growth hormone. J. Pediatr. Endocrinol.7:175–180.
88.
Kaneko, M., T. Nakayama, M. Kodama, and C. Nagata. 1984. Detection of DNA lesions in cultured human fibroblasts induced by active oxygen species generated from a hydroxylated metabolite of 2-naphthylamine. Gann75:349–506.
89.
Kemp, A., and G. Berke. 1973a. Effects of heparin and benzyl alcohol on lymphocyte-mediated cytotoxicity in vitro. Cell Immunol.7:512–515.
90.
Kemp, A., and G. Berke. 1973b. Inhibition of lymphocyte-mediated cytolysis by the local anesthetics benzyl and salicyl alcohol. Eur. J. Immunol.3:674–677.
91.
Kieckebusch, W., and K. Lang. 1960. Tolerance of benzoic acid in chronic feeding. Arzneimittel-Forsch.10:1001–1003. (In German—translation cited in FASEB, 1973.)
92.
Kimmel, C. A., J. G. Wilson, and H. J. Schumacher. 1971. Metabolism and identification of the causative agent in aspirin teratogenesis in rats. Teratology4:15–24.
93.
Kimura, E. T., T. D. Darby, R. A. Krause, and H. D. Brondyk. 1971. Parenteral toxicity studies with benzyl alcohol. Toxicol. Appl. Pharmacol.18:60–68.
94.
King, C.C., and L.L. Hart. 1994. Epidural administration of methylprednisolone acetate preserved with benzyl alcohol. Ann. Pharmacother.28:59–60.
95.
Kligman, A.M. 1970. A maximization test: The contact-sensitization potential of eight coded fragrance materials: 10% Benzyl Alcohol in petrolatum. Report to RIFM. 7 October. Unpublished data from The Research Institute for Fragrance Materials, Inc., Two University Plaza, Suite 406, Hackensack, NJ 07601.
96.
Kligman, A. M.1977. Maximization test: 2% Benzoic Acid in petrolatum. Report to RIFM. 24 May. Unpublished data from The Research Institute for Fragrance Materials, Inc., Two University Plaza, Suite 406, Hackensack, NJ 07601.
97.
Kligman, A. M.1990. The spectrum of contact urticaria. Wheals, erythema, and pruritus. Dermatol. Clin.8:57–60.
98.
Kramer, M., and R. Tarjan. 1962. Effects of preservatives on the utilization of carotene. Intern. Z. Vitaminforsch.32:149–157. (In German—translation cited in FASEB, 1973.)
99.
Kraut, E. H., M. Segal, and A. L. Sagone, Jr. 1982. Evaluation of the role of oxygen radicals in polymorphonuclear leukocyte aggregation. Inflammation6:161–167.
100.
Kreis, H., K. Frese, and G. Wilmes. 1967. Physiological and histological changes in rats fed benzoic acid. Food Cosmet. Toxicol.5:505–511. (German article, English abstract.)
101.
Kubota, K., and T. Ishizaki. 1991. Dose-dependent pharmacokinetics of benzoic acid following oral administration of sodium benzoate to humans. Eur. J. Clin. Pharmacol.41:363–368.
102.
Kumar, V., I. S. Anand, and N. K. Ganguly. 1993. Action of oxygen free radical scavengers and inhibitors on the chemiluminescence response of monocytes and neutrophils in rheumatic fever. Cardioscience4:171–175.
Lahti, A.1987. Terfenadine does not inhibit non-immunologic contact urticaria. Contact Dermatitis16:220–223.
105.
Lahti, A., V. Pylvänen, and M. Hannuksela. 1995. Immediate irritant reactions to benzoic acid are enhanced in washed skin areas. Contact Dermatitis33:177–182.
106.
Larmi, E.1989a. PUVA treatment inhibits non-immunologic immediate contact reactions to benzoic acid and methyl nicotinate. Int. J. Dermatol.28:609–611.
107.
Larmi, E.1989b. Systemic effect of ultraviolet irradiation on non-immunologic immediate contact reactions to benzoic acid and methyl nicotinate. Acta Dermatol. Venereol.69:296–301.
108.
Larmi, E., A. Lahti, and M. Hannuksela. 1988. Ultraviolet light inhibits non-immunologic immediate contact reactions to benzoic acid. Arch. Dermatol. Res.280:420–423.
109.
Larsen, W. G.1985. Perfume dermatitis. J. Am. Acad. Dermatol.12:1–9.
110.
Larsen, W. G.1989. How to instruct patients sensitive to fragrances. J. Am. Acad. Dermatol.21(4 pt 2):880–884.
111.
Lashmar, U. T., J. Hadgraft, and N. Thomas. 1989. Topical application of penetration enhancers to the skin of nude mice: A histopathological study. J. Pharm. Pharmacol.41:118–122.
112.
LeBel, M., L. Ferron, M. Masson, J. Pichette, and C. Carrier. 1988. Benzyl alcohol metabolism and elimination in neonates. Dev. Pharmacol. Ther.11:347–356.
113.
Leyden, J. J., and A. M. Kligman. 1977. Contact sensitization to benzoyl peroxide. Contact Dermatitis3:273–275.
114.
Levy, G. L., P. Amsel, and H. C. Elliott. 1969. Kinetics of salicyluric acid elimination in man. J. Pharm. Sci.58:827–829.
115.
Lewis, R. J. Sr. 1993. Hazardous chemicals desk reference, 3rd ed. New York: Van Nostrand Reinhold.
116.
Lide, D. R., ed. 1993. CRC handbook of chemistry and physics, 74th ed. Boca Raton, FL: CRC Press.
117.
Litton Bionetics, Inc.1974. Mutagenic evaluation of compound FDA 71–37, sodium benzoate. NTIS Report No. PB-245–453.
118.
London, R. E., and S. A. Gabel. 1988. A deuterium surface coil NMR study of the metabolism of D-methionine in the liver of the anesthetized rat. Biochemistry27:7864–7869.
119.
Lotte, C., R. C. Wester, A. Rougier, and H. I. Maibach. 1993. Racial differences in the in vivo percutaneous absorption of some organic compounds: A comparison between black, Caucasian and asian subjects. Arch. Dermatol. Res.284:456–459.
120.
Lucas, D. R.1909. Some effects of sodium benzoate. Proc. Soc. Exp. Biol. Med.6:122–126.
121.
Mahmood, N., S. G. Khan, S. Ali, M. Athar, and Q. Rahman. 1993. Asbestos induced oxidative injury to DNA. Ann. Occup. Hyg.37:315–319.
122.
Malanin, G., and K. Kalimo. 1989. The results of skin testing with food additives and the effect of an elimination diet in chronic and recurrent urticaria and recurrent angioedema. Clin. Exp. Allerg.19:539–543.
123.
Marquardt, P.1960. Tolerance of benzoic Acid. Arzneimittel-Forsch.10:1033.
124.
Martin, K. J., C. L. McConkey, Jr., T. J. Stokes, Jr. 1985. Effects of benzyl alcohol on PTH receptor-adenylate cyclase system of canine kidney. Am. J. Physiol.248(1 pt 1):E31-E35.
125.
Maswoswe, S. M., D. M. Cyr, A. D. Griffith, and G. C. Tremblay. 1986. The effect of sodium benzoate on ammonia toxicity in rats. Biochem. Biophys. Res. Common.138:369–373.
126.
McGregor, D. B., A. Brown, P. Cattanach, L. Edwards, D. McBride, C. Riach, and W. J. Caspary. 1988. Responses of the L5178Y tk-positive/tk-negative mouse lymphoma cell forward mutation assay III. 72 coded chemicals. Environ. Mol. Mutag.12:85–154. (Published erratum appears in Environ. Mol. Mutag.1988, 12:345.)
127.
Menon, P. A., B. T. Thach, C. H. Smith, M. Landt, J. L. Roberts, R. E. Hillman, and L. S. Hillman. 1984. Benzyl alcohol toxicity in a neonatal intensive care unit: incidence, symptomatology, and mortality. Am. J. Perinatol.1:288–292.
128.
Messiha, F. S.1991. Benzyl alcohol adverse effects in the rat: implications for toxicity as a preservative in parenteral injectable solutions. Comp. Biochem. Physiol.99:445–449.
129.
Messiha, F. S., A. Pasi, and G. Morniroli. 1992. Behavioral and enzymatic interactions between benzyl alcohol and ethanol. Pharmacol. Biochem. Behav.43:1071–1074.
130.
Minor, J. L., and J. A. Becker. 1971. A comparison of the teratogenic properties of sodium salicylate, sodium benzoate, and phenol. Toxicol. Appl. Pharmacol.19:373.
131.
Mitranic, M. M., J. M. Boggs, and M. A. Moscarello. 1982. The effect of linoleic acid and benzyl alcohol on the activity of glycosyltransferases of rat liver Golgi membranes and some soluble glycosyltransferases. Biochim. Biophys. Acta693:75–84.
132.
Montaguti, P., E. Melloni, and E. Cavalletti. 1994. Acute intravenous toxicity of dimethyl sulfoxide, polyethylene glycol 400, dimethyl-formamide, absolute ethanol, and benzyl alcohol in inbred mouse strains. Arzneimittel-Forsch.44:566–570.
133.
Montaño García, M. L., and M. Orea. (1989. Frequency of urticaria and angioedema induced by food additives. Rev. Alerg. Mex.36:15–18.
134.
National Toxicology Program (NTP).1989. Toxicology and carcinogenesis studies of benzyl alcohol (CAS No. 100–51–6) in F344/N rats and B6C3F1 Mice (gavage studies). NTIS Report No. PB90–110206.
135.
Needham, L., and M. D. Houslay. 1988. Tosyl-lysyl chloromethylketone detects conformational changes in the catalytic unit of adenylate cyclase induced by receptor and G-protein stimulation. Biochem. Biophys. Res. Commun.156:855–859.
136.
Nikitakis, J. M., and G. N. McEwen, Jr.. eds 1990. CTFA compendium of cosmetic ingredient composition—specifications.Washington, DC: CTFA.
137.
Njagi, G. D., and H. N. Gopalan. 1980. DNA and its precursors might interact with the food preservatives, sodium sulphite and sodium benzoate. Experientia36:413–414.
138.
O'Connor, J. E., M. Ribelles, and S. Grisolía1982. Potentiation of hyperammonemia by sodium benzoate in animals. A note of caution. Eur. J. Pediatr.138:186–187.
139.
O'Connor, J. E., M. Costell, and S. Grisolía. 1989. Carbamyl glutamate prevents the potentiation of ammonia toxicity by sodium benzoate. Eur. J. Pediatr.148:540–542.
140.
Ohmiya, Y., and K. Nakai. 1978. Interaction of benzyl alcohol with human erythrocytes. Jpn. J. Pharmacol.28:367–374.
141.
Ohno, Y., S. Sekigawa, H. Yamamoto, K. Nakamori, and Y. Tsubura. 1978. Additive toxicity test of sorbic acid and benzoic acid in rats. J. Nara. Med. Assoc.29:695–708.
142.
Oikawa, A., H. Tohda, M. Kanai, M. Miwa, and T. Sugimura. 1980. Inhibitors of poly(ADP ribose) polymerase induce sister chromatid exchanges. Biochem. Biophys. Res. Commun.97:1311–1316.
143.
Opdyke, D. L. J.1973. Monographs on fragrance raw materials. Benzyl Alcohol. Food Cosmetics Toxicol.11:1011–1081.
144.
Opdyke, D. L. J.1979. Monographs on fragrance raw materials. Benzoic acid. Food Cosmetics Toxicol.17:715–722.
145.
Oyanagi, K., Y. Kuniya, M. Nagao, A. Tsuchiyama, and T. Nakao. 1987. Cytotoxicities of sodium benzoate in primary culture of hepatocytes from adult rat liver. Tohoku. J. Exp. Med.152:47–51.
146.
Polish Academy of Sciences.1977. Teratologic examination of benzoic acid in rats. Teratologic examination of benzoic acid in golden hamsters. Project #: 05–611–4. Submitted by the FDA in response to a 1995 FOI request (42 pages.)2
147.
Prival, M. J., V. F. Simmon, and K. E. Mortelmans. 1991. Bacterial mutagenicity testing of 49 food ingredients give very few positive results. Mutat. Res.260:321–329.
148.
Przybyszewski, W. M., and J. Malec. 1982. Protection against hydroxyurea-induced cytotoxic effects in L5178Y cells by free radical scavengers. Cancer. Lett.17:223–228.
149.
Quick, A. J.1931. The conjugation of benzoic acid in man. J. Biol. Chem.92:65–85.
150.
Rademaker, M., and A. Forsyth. 1989. Contact dermatitis in children. Contact Dermatitis20:104–107.
151.
Rasmussen, L. H., M. Zachmann, and P. Nilsson. 1989. Authentic recombinant human growth hormone. Results of a multicenter clinical trial in patients with growth hormone deficiency. Helv. Paediatri. Acta43:443–448.
152.
Registry of Toxic Effects of Chemical Substances (RTECS).1995. Benzoic Acid. Toxnet database. Bethesda, MD: National Library of Medicine.
153.
Reynolds, R. D., and R. M. Smith. 1995. Nebulized bacteriostatic saline as cause of bronchitis. J. Fam. Pract.40:35–40.
154.
Rogan, E. G., E. L. Cavalieri, B. A. Walker, R. Balasubramanian, P. G. Wislocki, R. W. Roth, and R. K. Saugier. 1986. Mutagenicity of benzylic acetates, sulfates and bromides of polycyclic aromatic hydrocarbons. Chem. Biol. Interact.58:253–275.
155.
Roskos, K. V., H. I. Maibach, and R. H. Guy. 1989. The effect of aging on percutaneous absorption in man. J. Pharmacokinet. Biopharm.17:617–630.
156.
Rothschild, D. L., Jr. 1990. The Food Chemical News Guide guide to the current status of food additives and color additives.Washington, DC: Food and Chemical News.
157.
Rotstein, J. B., and T. J. Slaga. 1988. Effect of exogenous glutathione on tumor progression in the murine skin multistage carcinogenesis model. Carcinogenesis9:1547–1551.
158.
Rougier, A., D. Dupuis, C. Lotte, R. Roguet, R. C. Wester, and H. I. Maibach. 1986. Regional variation in percutaneous absorption in man: measurement by the stripping method. Arch. Dermatol. Res.278:465–469.
159.
Safford, R. J., D. A. Basketter, C. F. Allenby, and B. F. Goodwin. 1990. Immediate contact reactions to chemicals in the fragrance mix and a study of the quenching action of eugenol. Br. J. Dermatol.123:595–606.
160.
Sanchez-Borges, M., and R. Suarez-Chacon. 1992. Additives in allergic or pseudo-allergic reactions. Prog. Allergy. Clin. Immunol.333–338.
161.
Santucci, L. G., ed. 1999. List of Japanese cosmetic ingredients.4rd ed. Washington, DC: CTFA.
162.
Shiseido Research Center.1972. Primary skin irritation (rabbit) and cumulative skin irritation (guinea pig) testing 10% Benzyl Alcohol in squalane. Unpublished data submitted by CTFA. (5 pages.)2
163.
Shtenberg, A. J., and A. D. Ignatév. 1970. Toxicological evaluation of some combinations of food preservatives. Food Cosmetics Toxicol.8:369–380.
164.
Shriner, D. L., and H. I. Maibach. 1996. Regional variation of nonimmunologic contact urticaria. Functional map of the human face. Skin Pharmacol.9:312–321.
165.
Smyth, H. F., Jr., and C. P. Carpenter. 1948. Further experience with the range-finding test in the industrial toxicology laboratory. J. Ind. Hyg. Toxicol.30:63–68.
166.
Smyth, H. F., Jr., C. P. Carpenter, and C. S. Weil. 1951. Range-finding toxicity data: List IV. Arch. Ind. Hyg. Occup. Med.4:119–122.
167.
Sodemoto, Y., and M. Enomoto. 1980. Report on the carcinogenesis bioassay of sodium benzoate in rats: absence of carcinogenicity of sodium benzoate in rats. J. Environ. Pathol. Toxicol.4:87–95.
168.
Spustová, V., and C. Oravec1989. Antitumor effect of hippurate. An experimental study using various mouse tumor strains. Neoplasma36:317–320.
169.
Sugioka, K., H. Nakano, J. Tsuchiya, M. Nakano, and Y. Sugioka. 1984. Clear evidence for the participation of OH in lambda DNA breakage induced by the enzymatic reduction of adriamycin in the presence of iron-ADP. Importance of local OH concentration for DNA strand cleavage. Biochem. Int.9:237–242.
170.
Suthanthiran, M., S. D. Solomon, P. S. Williams, and A. L. Rubin. 1984. Hydroxyl radical scavengers inhibit human natural killer cell activity. Nature307:276–278.
171.
Tanaka, R.1984. Effect of benzyl alcohol on adenosine triphosphatase, p-nitrophenylphosphatase and acetylcholinesterase in rat erythrocyte membrane. J. Toxicol. Sci.9:109–116.
172.
Taylor, E. J., ed. 1988. Dorland's illustrated medical dictionary, 27th ed., 200. Philadelphia, PA: WB Saunders.
173.
Testa, M., G. Iuliano, P. Morton, and A. Longoni. 1987. Topical benzyl alcohol reduces cataract surgery need: Two long-term double blind studies. J. Ocul. Pharmacol.3:211–225.
174.
Thomas, M. J., S. Smith, and J. A. Pang. 1991. The use of water-soluble radical scavengers to detect hydroxyl radical formation by polymorphonuclear leukocytes. Free. Radic. Res. Commun.12-13(pt 1):53–57.
175.
TKL Research.1991. 28-Day safety in-use study of eye shadow containing 0.1% Benzoic Acid. TKL No. 919226. Unpublished data submitted by CTFA. (240 pages.)2
176.
Toth, B.1984. Lack of tumorigenicity of sodium benzoate in mice. Fundam. Appl. Toxicol.4(3 pt 1):494–496.
177.
Tremblay, G. C., and I. A. Qureshi. 1993. The biochemistry and toxicology of benzoic acid metabolism and its relationship to the elimination of waste nitrogen. Pharmacol. Ther.60:63–90.
178.
Uno, Y., H. Takasawa, M. Miyagawa, Y. Inoue, T. Murata, and K. Yoshikawa. 1994. An in vivo-in vitro replicative DNA synthesis (RDS) test using rat hepatocytes as an early prediction assay for nongenotoxic hepatocarcinogens screening of 22 known positive and 25 noncarcinogens. Mutat. Res.320:189–205.
179.
Upreti, K. K., M. Das, and S. K. Khanna. 1991. Role of antioxidants and scavengers on argemone oil-induced toxicity in rats. Arch. Environ. Contam. Toxicol.20:531–537.
180.
van der Hal, A. L., H. M. MacDonald, L. Shaw, S. Sreepathi, and S. A. Beasley. 1987. Benzyl alcohol in neuromuscular blocking agents [letter]. Pediatrics79:841–842.
181.
Van Joost, T., E. Stolz, and J. C. S. Van der Hoek. 1985. Simultaneous allergy to perfume ingredients. Contact Dermatitis12:115–116.
182.
Voorheis, H. P., and B. R. Martin. 1982. Local anesthetics including benzyl alcohol activate the adenylate cyclase in Trypanosoma brucei by a calcium-dependent mechanism. Eur. J. Biochem.123:371–376.
183.
Walker, P. D., and S. V. Shah. 1988. Evidence suggesting a role for hydroxyl radical in gentamicin-induced acute renal failure in rats. J. Clin. Invest.81:334–341.
184.
Weitberg, A. B., S. A. Weitzman, E. P. Clark, and T. P. Stossel. 1985. Effects of antioxidants on oxidant-induced sister chromatid exchange formation. J. Clin. Invest.75:1835–1841.
185.
Weitzman, S. A., and T. P. Stossel. 1982. Effects of oxygen radical scavengers and antioxidants on phagocyte-induced mutagenesis. J. Immunol.128:2770–2772.
186.
Wenninger, J. A., R. C. Canterbery, and G. N. McEwen, Jr., eds. 2000. International cosmetic ingredient dictionary and handbook.8th ed., Vol. I, 126, 131, Vol. 2, 1255. Washington, DC: CTFA.
187.
White, A.1941. Growth inhibition produced in rats by the oral administration of sodium benzoate. Effects of various dietary supplements. Yale. J. Biol. Med.13:759–768.
188.
Wightman, M. A., and R. W. Vaughan. 1976. Comparison of compounds used for intradermal anesthesia. Anesthesiology45:687–689.
189.
Wiley, H. M., and W. D. Bigelow. 1908. Influence of benzoic acid and benzoates on digestion and health. Bulletin 84, pt. IV, Bureau of Chemistry, U.S. Department of Agriculture.
190.
Williams, J. M., and N. R. Howe. 1994. Benzyl Alcohol attenuates the pain of lidocaine injections and prolongs anesthesia. J. Dermatol. Surg. Oncol.20:730–733.
191.
Wüthrich, B., and L. Fabro. 1981. Acetylsalicylic acid and food additive intolerance in urticaria, bronchial asthma and rhinopathy. Schweiz Med. Wochenschr.111:1445–1450.
192.
Zeiger, E., B. Anderson, S. Haworth, T. Lawlor, and K. Mortelmans. 1988. Salmonella mutagenicity tests: IV. Results from the testing of 300 chemicals. Environ. Mol Mutag.11(Suppl. 12):1–158.
